Project Grant HT94252311052
Award Date
9/30/23
Completion Date
9/29/26
Dollars Obligated
$1.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02215, USA
Similar Awards
This federal Project Grant award in the amount of $1,991,326.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award supports research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) to investigate the "Suppression of Barrier Antimicrobial Defenses by Trauma" over a three-year performance period from September 30, 2024 to September 29, 2027. As a major academic medical center and teaching hospital, Bidmc...
This federal Project Grant award of $518,700.00 was made by the Defense Health Agency on July 1, 2024 to the Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, MA. The award is part of the Military Medical Research and Development (CFDA 12.420) program, which supports biomedical research initiatives to improve health outcomes for military service members, veterans, and the broader public.
The funding will support Bidmc's project titled "EXPLOITING DISRUPTION IN TRANSCRIPTIONAL...
The Department of the Army Medical Command awarded Beth Israel Deaconess Medical Center, Inc. (doing business as Bidmc) a $6,766,843 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2021 through May 2025 to investigate Aryl Hydrocarbon Receptor innate immune modulators for the treatment of Inflammatory Bowel Disease. The Military Medical Research and Development program supports basic, applied, and advanced...
The Beth Israel Deaconess Medical Center, Inc. (doing business as Bidmc) received a $1,735,624 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program.
The grant will fund research from July 1, 2021 to June 30, 2025 to develop a strain-programmable bioadhesive patch to accelerate healing of diabetic ulcers. The Military Medical Research and Development program aims to transform military and public health through...
The Beth Israel Deaconess Medical Center, Inc. (Bidmc) received a $532,228 Cooperative Agreement award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award, effective September 15, 2024 through September 14, 2026, will support Bidmc's participation as a clinical trials site for the Kidney Cancer Research Consortium. As a leading academic medical center, Bidmc will leverage its expertise in cancer research to contribute to...
This $1,994,937 federal Project Grant award, funded by the U.S. Department of Defense through the Military Medical Research and Development program (CFDA 12.420), is supporting research to confirm the effectiveness of acupuncture in treating the symptoms of Gulf War Illness. The grant recipient, Beth Israel Deaconess Medical Center, Inc. (Bidmc), a prominent academic medical center in Boston, will conduct this research project over a 4-year period from August 2024 to July 2028. Bidmc has...
This $345,800 Project Grant was awarded on May 1, 2024 by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts. The grant supports research on the "Role of Stress Granules in the Pathogenesis and Therapy of Pulmonary Hypertension", with a performance period from May 1, 2024 to April 30, 2026.
The Military Medical Research and Development program funds a...
This $472,560.00 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, MA to target mutant protein degradation for therapeutic intervention of genetic focal segmental glomerulosclerosis (FSGS). The 2-year award period runs from January 1, 2025 to December 31, 2026. Bidmc is a prominent academic medical center and leading research institution...
The Beth Israel Deaconess Medical Center, Inc. (Bidmc) in Boston, Massachusetts was awarded a $1,296,751 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on June 1, 2024, will fund a 2-year research project titled "Electrical Impedance Myography via the Myolex mScan as an ALS Biomarker." The goal of the project is to evaluate a novel diagnostic approach using electrical impedance...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) provides $2,531,888 to Beth Israel Deaconess Medical Center, Inc. (Bidmc) to study "CORRECTING CYTOSKELETAL ABNORMALITIES AND PODOCYTE VULNERABILITY IN FOCAL SEGMENTAL GLOMERULOSCLEROSIS." The 4-year award, starting on May 1, 2024, supports Bidmc's research aimed at improving treatments for this kidney disorder. As a leading academic medical center, Bidmc has an...